Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Cardiac Amyloidosis Using Positron Emission Tomography (PET/CT)
Sponsor: University of Pennsylvania
Terminated
Low accrual
Other terminated trials from University of Pennsylvania
Other Cardiac Amyloidosis trials with similar outcome
Listed as NCT04105634, this EARLY_PHASE1 trial focuses on Cardiac Amyloidosis and remains terminated or withdrawn. Sponsored by University of Pennsylvania, it has been updated 12 times since 2019, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Dec 2024 — Present [monthly]
Terminated EARLY_PHASE1
Status: Active Not Recruiting → Terminated
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2023 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
▶ Show 7 earlier versions
-
Oct 2022 — Nov 2023 [monthly]
Recruiting EARLY_PHASE1
-
Oct 2021 — Oct 2022 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2021 — Oct 2021 [monthly]
Recruiting EARLY_PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
Status: Active Not Recruiting → Recruiting
-
Apr 2020 — Oct 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Dec 2019 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Dec 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .